Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

APGE Apogee Therapeutics Inc

50,31

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:09:34

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Apogee Therapeutics (NASDAQ:APGE)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Apogee Therapeutics Charts.

Apogee Therapeutics (NASDAQ:APGE)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Apogee Therapeutics Charts.

News Apogee Therapeutics Inc

Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
Mittwoch 15 Mai 2024 (5 Tage vor) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Montag 13 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
Montag 13 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference
Montag 6 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
Montag 25 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million
Dienstag 12 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 424B4 - Prospectus [Rule 424(b)(4)]
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering
Freitag 8 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Apogee Therapeutics Inc News-Artikel

Fancamp Exploration

Amneal Pharmaceuticals

Yara International ASA

Amundi MSCI Eastern Euro...

Western Copper and Gold

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen